The 42nd Annual J.P. Morgan Healthcare Conference (hereinafter referred to as "JPM Conference") was held on January 8-11, 2024 in San Francisco, California, USA. The conference invited "big names" from the pharmaceutical industry and the international investment and financing community to discuss cutting-edge advances in the industry and new trends for future development. Three companies incubated by Rehabilitation Capital's New Drug Innovation Fund, namely, StarMed Unigene, StarNucleus Disease, and StarOptoVision, attended the JPM conference and delivered speeches in the biotechnology session, which gained great response. The company deeply participated in the international exchange of global biopharmaceuticals, laying the foundation for future innovation cooperation and exploring sustainable cooperation opportunities.

JPM Conference has been held for 41 years since 1983, is the largest and most informative healthcare investment seminar in the global biomedical health field, which connects nearly 10,000 industry leaders, representatives of innovative enterprises, technology developers and investors worldwide, and is regarded as the "wind vane" of the industry.

https://mp.weixin.qq.com/s/mZWoRhSzob5kBPEgVSHZWw